Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatmentFu-Ling Chang(Taipei Medical University), Yu‐Ching Lee(Taipei Medical University)HeliyonNovember 1, 202310.1016/j.heliyon.2023.e21774Cited by 7SaveCiteExport RISWatch citationsRelated PapersPSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression|Nature Communications|2019|43